Key result
Senescent endothelial microvesicles drive diabetic vascular injury and heighten cardiovascular risk via microRNA signaling.
Answers are grounded in this paper and cite their sources.
Endothelial senescence-associated with aging or induced prematurely in pathological situations, such as diabetes, is a first step in the development of Cardiovascular Disease (CVDs) and particularly inflammatory cardiovascular diseases. The main mechanism that links endothelial senescence and the progression of CVDs is the production of altered Extracellular Vesicles (EVs) by senescent endothelial cells among them, Microvesicles (MVs). MVs are recognized as intercellular signaling elements that play a key role in regulating tissue homeostasis. However, MVs produced by damage cell conveyed epigenetic signals, mainly involving microRNAs, which induce many of the injured responses in other vascular cells leading to the development of CVDs. Many studies strongly support that the quantification and characterization of the MVs released by senescent endothelial cells may be useful diagnostic tools in patients with CVDs, as well as a future therapeutic target for these diseases. In this review, we summarize the current knowledge linking senescence-associated MVs to the development of CVDs and discuss the roles of these MVs, in particular, in diabetic-associated increases the risk of CVDs.
No takes yet. Share an insight, caveat, or question.
Carracedo et al. (2018) conducted a review in Cardiovascular disease associated with diabetes mellitus. Senescence-associated endothelial microvesicles was evaluated on Development and progression of cardiovascular diseases. Senescence-associated endothelial microvesicles convey epigenetic signals like microRNAs that drive vascular injury and increase cardiovascular disease risk in diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: